CRON's PEACE NATURALS® Secures Major Distribution Deal Across Swiss Medical Cannabis Market

Cronos Group Inc. (NASDAQ: CRON) has strengthened its European medical cannabis presence through a strategic distribution arrangement with Dascoli Pharma AG, a leading Swiss pharmaceutical distributor. The deal positions PEACE NATURALS®-branded products directly within Switzerland’s regulated medical channels, marking a significant milestone for the Toronto-based company’s continental expansion efforts.

Distribution Network Expansion in Europe’s Regulated Market

The collaboration leverages Dascoli’s established retail and wholesale infrastructure across Switzerland to make PEACE NATURALS® cannabis flower available to patients and healthcare providers. Cronos supplies five distinct cultivar variants through this arrangement: GMO Cookies, Space Cake, Atomic Sour Grapefruit, Sonic Lemon Fuel, and Wedding Cake. These products will reach Swiss patients via pharmacies and clinical partners within Dascoli’s distribution network, which operates nationwide next-day home delivery capabilities.

Building a Cross-Border Medical Cannabis Portfolio

This Swiss expansion follows recent product launches in Australia and Malta, broadening PEACE NATURALS® availability across multiple continents. The brand now operates in seven established markets: Canada, Germany, Israel, Malta, Switzerland, the United Kingdom, and Australia. This geographic diversification reflects Cronos’ strategy to capture opportunities across mature and emerging regulated medical cannabis jurisdictions.

Strategic Rationale Behind the Partnership

Mike Gorenstein, Chairman, President and CEO at Cronos, emphasized the significance of strengthening the company’s footprint through experienced local partners. By utilizing Dascoli’s pharmaceutical infrastructure and market knowledge, Cronos reduces barriers to market entry while maintaining compliance with Switzerland’s stringent medical cannabis regulations. The partnership demonstrates how established distribution networks can accelerate product penetration in regulated healthcare environments.

About the Companies

Cronos operates as a diversified cannabinoid company developing intellectual property through cannabis research and product innovation. The company’s international portfolio includes multiple brands serving both medical and consumer segments. Dascoli, headquartered in Zurich, specializes in compliant cannabinoid therapies distributed through wholesale, retail, and direct-to-patient channels across Switzerland’s healthcare system.